Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Health Catalyst Q4 2023 GAAP EPS $0.02, Sales $75.08M Beat $73.60M Estimate

Author: Benzinga Newsdesk | February 22, 2024 05:15pm
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.02 per share. The company reported quarterly sales of $75.08 million which beat the analyst consensus estimate of $73.60 million by 2.01 percent. This is a 8.56 percent increase over sales of $69.16 million the same period last year.

Posted In: HCAT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist